also, being "positioned for growth" was not the objective
the bonds HAD to be resolved because they were secured by the manufacturing facilities, and the balance sheet needed to be strengthened to carry the abuse resistant line through studies and possibly (but hopefully not) some additional studies/trials for the FDA
let's see, 32% of the 26% of those suspected, or on average 4.5 out of 55 patients...
hmm-mm, best pass this on to MD Anderson as they may not be aware of this definitive study
that is all the result of selling more shares to Lincoln, and the money from Novel
btw, the bond series paid off was for $450k and was due for redemption September 2012
the bond series that remains was the longer term and larger amount, and payments are now current
the actual statement included accumulation of immune cells but instead of the "and/or" Northwest should have announced how many of the nine fell into each of the categories
"all 9 of these 9 patients are showing tumor cell death, tumor shrinkage, substantial accumulation of immune cells in the tumors, and/or stabilization of the patients’ disease."
what is your point
everything in the money is exercised
why is keeping it between 6 and 7 any better than keeping it between 5 and 6 or 7 and 8
will happen next month and the next month
if you know with certainty that some game is being played why not share with us how to take advantage
checked the price for July 2nd and it was almost 50% higher
guess "the only person you will be able to blame is yourself" for losing a big slug of your paper profits
have to say it is refreshing to finally hear someone say "cant blame the shorts or MMs."
surprised nobody came forward to correct me
as it turns out, the operating loss was greater than R&D spending
maybe with a couple more drugs they can close that gap
regardless, Hakim needs to spend on R&D what he needs to spend
"And NET INCOME (LOSS) to Common Shareholders has gone from $922K to ($4,4M)."
actually, the $4.4 million loss included the gain from Novel, so true loss was about $6.1 million
and, despite all the smarmy, angry, sarcastic rebuttals you have received crediting this big change to increased R&D, let me point out that the increase was NOT $4 million and that all other operating expenses have also gone up -- with good reason, but i just wish to point out the simplistic nature of those rebuttals
but a very large component of that loss is one that seems to escape this board over and over and over ever since i first noted some years back (when folks were bragging about elite making so much money) that whenever the stock goes up elite will show a loss on its books, and whenever the stock goes down it will show as a loss, until they get rid of all the... derivatives
mannkind has been a magnet for margin traders
basically the same thing you said back in June
June 24th you predicted .48 on three million shares but it did neither and has been down ever since
it is good that you don't yap about generic revenues anymore (especially since a 60% increase over a very lousy quarter is not good to say the least) but why did you think we would close in the .40's and then keep going up at this particular juncture?
Hakim can't create news for earnings reports. the studies will be done when they are done and it is not likely even those results will move the stock much, or even the submission to the FDA
what WILL move the stock would be the FDA putting Hakim's first drug on fast track or at least saying that additional trials will not be necessary.
didn't make sense to me either
kept looking for slight change in the id that would indicated someone stealing it
but it the writing style is his
cannot understand why he is questioning what the DMC Chair clearly said, let alone acknowledge the significance of Chair even stepping out like that to make a public statement defending Northwest
" I do know that the DMC was tasked with and did look at the efficacy data,"
How is it that you have come to know this information that is unavailable to everybody else except for those working on the DMC?
Why don't YOU provide a link with sp0eciic language that supports y9our out4rageous claim that you KNOW an efficacy analysis was performed -- especially since the only current news from the DMC is a direct contradiction to your claim.
This news is posted by PR News wire.
gordo, that was a full year to full year comparison and, again it was only 7% higher than 2011
you cannot seem to understand that comparing the same quarter last year with the 4th quarter this year, revenues were DOWN
on the other hand, now that 1st quarter revenues are up from last year's 1st quarter you have suddenly warmed up to quarter to quarter comparisons
hmm-mm, but what you still don't like to look at is sequential quarterly comparisons because, guess what, this quarter did no better than the previous quarter!
btw, it was no great feat to achieve a 60% improvement over last year's 1st quarter because it was a real big disappointment last year
and a nice healthy increase in R&D is just what the doctor ordered
revenues could have been better given the very weak quarter in the comparison, but revenues are of little importance at this point except to offset some of the R&D costs and limit the need for more dilution
elite ended its best year ever on a very, very sour note with a DOWN quarter which was my FACTUAL statement that gordo refuses to accept
and, that "best year ever" was just 7% above FY 2011
oh, and it is easy for any company to finish the year with money if they sell enough shares
so, plan and simple, you and gordo are confirmed pumpers
and, you also had dead money here for all the years of jerry
those who bought when Hakim took over and we said we were going all in are doing just as well as you boys but they have the credibility you lost by pumping for years when there was nothing pumpworthy
five percent interest
can also sell calls against convertible shares
but i would be happy to collect interest until mandatory conversion in three years
the statement in quotes was made by the Chairman of the DMC, it was NOT made by Northwest. now, if you don't believe he was quoted correctly in the press release don't you think he would have notified Northwest of the error? would a notarized version help, or are you questioning if he is really the Chairman, or if there even is a DMC? i mean how deep does your distrust of Linda go, and when did it start? and conversely, when did you become an infatuated believer in those attacking the integrity of Linda with absolutely no proof?
would take out a second mortgage to get in on that
Northwest has had no problem whatsoever raising the money it needs
as largest shareholder, Linda is not interested in dilution beyond short term needs
perhaps raising in small amounts means revenues will be starting soon from Germany